Penny Wise, Dollar Foolish Approach to Antiemetic Use May Compromise Patient Care

Por Hesketh, Paul J.
Publicado em 2009

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting

Por Hesketh, Paul J., Aapro, Matti, Jordan, Karin, Schwartzberg, Lee, Bosnjak, Snezana, Rugo, Hope
Publicado no Biomed Res Int (2015)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Por Basch, Ethan, Hesketh, Paul J., Kris, Mark G., Prestrud, Ann Alexis, Temin, Sarah, Lyman, Gary H.
Publicado em 2011

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program

Por Aapro, Matti, Hesketh, Paul J., Jordan, Karin, Gralla, Richard J., Rossi, Giorgia, Rizzi, Giada, Palmas, Marco
Publicado no Oncologist (2016)

COMPARISON OF PLATINUM BASED CHEMOTHERAPY IN PATIENTS OLDER AND YOUNGER THAN 70 YEARS OF AGE: AN ANALYSIS OF SOUTHWEST ONCOLOGY GROUP TRIALS 9308 AND 9509

Por Blanchard, Elizabeth M., Moon, James, Hesketh, Paul J., Kelly, Karen, Wozniak, Antoinette J., Crowley, John, Gandara, David
Publicado em 2011

Efficacy of the neurokinin‐1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin‐based chemotherapy

Por Hesketh, Paul J., Schnadig, Ian D., Schwartzberg, Lee S., Modiano, Manuel R., Jordan, Karin, Arora, Sujata, Powers, Dan, Aapro, Matti
Publicado no Cancer (2016)

Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

Por Sangha, Randeep, Davies, Angela M., Lara, Primo N., Mack, Philip C., Beckett, Laurel A., Hesketh, Paul J., Lau, Derick, Li, Tianhong, Perkins, Natasha, Gandara, David R.
Publicado em 2011

SWOG 0709: Randomized Phase II Trial of Erlotinib vs. Erlotinib plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as...

Por Lara, Primo N., Moon, James, Hesketh, Paul J., Redman, Mary W., Williamson, Stephen K., Akerley, Wallace L., Hirsch, Fred R., Mack, Philip C., Gandara, David R.
Publicado no J Thorac Oncol (2015)

SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2

Por Hesketh, Paul J., Chansky, Kari, Wozniak, Antoinette J., Hirsch, Fred R., Spreafico, Anna, Moon, James, Mack, Philip C., Marchello, Benjamin T., Franklin, Wilbur A., Crowley, John J., Gandara, David R.
Publicado em 2008

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based...

Por Raftopoulos, Haralambos, Laadem, Abderrahmane, Hesketh, Paul J., Goldschmidt, Jerome, Gabrail, Nashat, Osborne, Cynthia, Ali, Muhammad, Sherman, Matthew L., Wang, Ding, Glaspy, John A., Puccio-Pick, Marie, Zou, Jun, Crawford, Jeffrey
Publicado no Support Care Cancer (2015)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Por Basch, Ethan, Prestrud, Ann Alexis, Hesketh, Paul J., Kris, Mark G., Feyer, Petra C., Somerfield, Mark R., Chesney, Maurice, Clark-Snow, Rebecca Anne, Flaherty, Anne Marie, Freundlich, Barbara, Morrow, Gary, Rao, Kamakshi V., Schwartz,, Rowena N., Lyman, Gary H.
Publicado no J Clin Oncol (2011)